Voyager Therapeutics
VYGR
VYGR
69 hedge funds and large institutions have $143M invested in Voyager Therapeutics in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 23 increasing their positions, 19 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.15% less ownership
Funds ownership: 62.6% → 62.45% (-0.15%)
10% less funds holding
Funds holding: 77 → 69 (-8)
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
Holders
69
Holding in Top 10
1
Calls
$4.47M
Puts
$440K
Top Buyers
| 1 | +$4.93M | |
| 2 | +$1.71M | |
| 3 | +$1.3M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.12M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.07M |
Top Sellers
| 1 | -$5.7M | |
| 2 | -$2.99M | |
| 3 | -$827K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$551K |
| 5 |
E
Ergoteles
New York
|
-$344K |